In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing-Reference-Cited by-同舟云学术

In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing

Published:2020-09 Issue:9 Volume:13 Page:1210-1223
ISSN:1876-0341
Container-title:Journal of Infection and Public Health
language:en
Short-container-title:Journal of Infection and Public Health

Author:

Kumar Yogesh^ORCID,Singh Harvijay,Patel Chirag N.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine

Reference52 articles.

1. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N Engl J Med,2020

2. WHO coronavirus disease (COVID-19) dashboard. n.d. https://covid19.who.int/. [Accessed 15 May 2020].

3. Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial;Hung;Lancet,2020

4. Gilead to end coronavirus drug trials, adding to access worry — researchers,2020

5. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study;Chen;Lancet,2020

Cited by 187 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Raman spectroscopy study of 7,8-dihydrofolate inhibition on the Wuhan strain SARS-CoV-2 binding to human ACE2 receptor;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-05

2. In silico antiviral properties of Spirulina platensis phycobiliprotein and phycobilin as natural inhibitor for SARS-CoV-2;Algal Research;2024-04

3. Myrtucommulones and Related Acylphloroglucinols from Myrtaceae as a Promising Source of Multitarget SARS-CoV-2 Cycle Inhibitors;Pharmaceuticals;2024-03-28

4. Computational Repurposing of Potential Dimerization Inhibitors against SARS-CoV-2 Main Protease;Letters in Drug Design & Discovery;2024-03

5. Development of a potent recombinant scFv antibody against the SARS-CoV-2 by in-depth bioinformatics study: Paving the way for vaccine/diagnostics development;Computers in Biology and Medicine;2024-03